Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Looking for under-the-radar adventures? Try Norway's Vesterålen - 2Make your choice for the sweet that transports you to its nation of beginning!
- 3The Specialty of Cleaning up: Change Your Space and Brain
- 4Scientists Just Discovered Japan’s First New Bird Species in Over 40 Years
- 5This Underrated Italian City Boasts Indulgent Food & Captivating Views For A Romantic Escape
- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- Traveling Alone: An Excursion of Self-Disclosure
- The Best Games On the planet
- What you need to know about Trump accounts as Michael and Susan Dell donate $6 billion to the new early childhood investment program
- 'No Kings' protests live updates: More than 8 million turned out across all 50 states, organizers say
- Shas threatens to oppose 2026 state budget over haredi food-voucher exclusion
- Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
- Delta flight bound for Atlanta makes emergency landing after engine issue
- Vietnam rethinks its flood strategy as climate change drives storms and devastation
